
Argentina Covid-19: new requirement relating to critical sanitary supplies
Amid the COVID-19 sanitary emergency, the Ministry of Health and the Ministry of Productive Development issued a joint resolution by which companies producing, distributing and commercializing critical sanitary supplies that mitigate the spread of COVID-19 or treat it therapeutically or cure it, are summoned to increase the production, distribution and commercialization of these supplies to the maximum of their installed capacity.
It was also established that the companies dedicated to the commercialization and distribution of said supplies must grant purchasing priority to the sanitary entities determined by the Ministry of Health.
The manufacturing of critical sanitary supplies must be reported to ANMAT by submitting an application on the “Remote Procedures” (TAD) platform of the “Electronic Document Management” (GDE) system.
To access the instructions to carry out this procedure, click here.
LIST OF CRITICAL SANITARY SUPPLIES
I. EQUIPMENT
Adult Ventilator – Pediatric Transport Ventilator – Volumetric infusion pumps – Syringe infusion pumps – Hospital Bed – Intensive Care Bed – Cardiac arrest cart with defibrillator – Multiparametric monitor – Pulse oximeter (With display) – Pulse oximeter – Active humidifiers – Portable ultrasound – Manual resuscitator – Manual aspirators – Foot blood pressure monitor – Oxygen tubes Equipment for delivery of Extracorporeal Circulation with Membrane Oxygenation (ECMO) – Oxygen Concentrators -Thermometers with Digital Reader and Alert Beep
II. PROTECTION ELEMENTS
Triple Layer Surgical Chinstraps – Disposable gowns – Latex Examination Gloves – Protective goggles for medical use – Alcohol gel per 250/300 ml with dosing pump – Dacron swabs with transport tube – N95 mask chinstraps (homologable to FPP2) – Disinfectant detergent for surfaces and medical devices – Disinfectant detergent cleaner for floors, walls and medical devices – Repellent Spray – Mortuary bag
III. MEDICINE
Amoxicillin + clavulanic acid – Amoxicillin – Azithromycin – Budesonide aerosol – Cefalexine – Dexamethasone – Loratadine – Ibuprofen -Meprednisone – Paracetamol – Benzathine penicillin g – Salbutamol aerosol.
For more information and/or legal advice,
please contact:

Coronavirus working breakfast
Excellent working breakfast about Coronavirus (COVID-19) in which the infectiologist Dr. Jorge Alejandro San Juan explained the what, how and why of the virus declared international emergency by WHO.

Lecture on IP at CEIPI in Strasbourg
Emilio Berkenwald was invited once again by CEIPI in Strasbourg to lecture on Intellectual Property in Argentina #CEIPI #PropriétéIntellectuelle #IntellectualProperty

IAM Global Leaders 2020
We are delighted to share that Managing Partner Alicia Alvarez Berkenwald has been listed in IAM’s brand new guide: “Global Leaders 2020” released on January 13, 2020. More info: https://www.iam-media.com/iam-global-leaders

Impact of Trademarks in Latin America
Our Partner Lucía Scarpati presented the results of the joint INTA-ASIPI Study on the Economic Impact of Trademark Intensive Industries in Latin America and Caribbean Countries at INTA’s ISC Meeting in Austin, TX. Study deliverables at http://inta.org/impactstudies.

The AR PTO joins WIPO’s Digital Access Service
The AR PTO joins WIPO’s Digital Access Service for the exchange of priority documents of patents and utility models. As from October 01, 2019, the AR PTO will be an Accessing Office and as from March 02, 2020, a Depositing Office.

GRUR’s Annual Meeting in Frankfurt
Gaining insight on German IP Law at the Annual Meeting of the German Association for the Protection of Intellectual Property (GRUR) in Frankfurt

CIPA’s Annual Congress in London
Emilio Berkenwald attends the CIPA (The Chartered Institute of Patent Attorneys) Congress 2019 in London.


Our team at AIPPI 2019 in London
Our team at AIPPI 2019 in London from left to right: Emilio Berkenwald, Alicia Alvarez Berkenwald and Federico Ulled.


